RDIF: media attacks on Sputnik V become more frequent

The Russian Direct Investment Fund announced an increase in the frequency of information attacks on the Sputnik V vaccine in the media. Such news, according to RDIF, is based “on false and misleading information received from anonymous sources.”

“This came after official research showed that the effectiveness of foreign mNRK vaccines against the Delta variant of COVID-19 fell below 50% after just five months. At the same time, even the single-component Sputnik Light vaccine showed a higher efficiency of protection against the Delta variant in the third month of vaccination than two-component foreign mRNA vaccines, ”the Foundation’s press service said.

RDIF urged Western manufacturers of mNRK vaccines not to attack the Russian drug, but “to consider using the single-component Sputnik Light vaccine as a booster to achieve stronger and longer-lasting immunity.”

Earlier, Reuters, citing sources, said that the European Medical Agency (EMA) still considers the data on the Russian vaccine against the Sputnik V coronavirus insufficient and is unlikely to approve its use until the first quarter of 2022. Prior to that, RDIF expressed hope that EMA representatives would return to Russia this autumn to continue the procedures for registering Sputnik V in the EU. Yesterday, October 20, the World Health Organization resumed the vaccine recognition procedure.

About how the world recognizes the Russian vaccine – in the material “Kommersant FM” “Sputnik V is preparing for recognition.”



Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent News

Editor's Pick